Chandra Vargeese
Chief Technology OfficerDr. Chandra Vargeese, PhD, is Chief Technology Officer and was Head of Platform Discovery Sciences of Wave Life Sciences, Inc. from September 2022 and served as its Senior Vice President of Platform & Discovery Sciences and Senior Vice President of Drug Discovery from August 2014 to April 2020. Before joining WAVE, Dr. Vargeese served as an Executive Director and Head of RNA Chemistry and Delivery at Novartis from 2008 to 2014. Prior to joining Novartis, Dr. Vargeese led siRNA delivery in the RNA Therapeutics division at Merck & Co. where she served as Senior Director and Head of RNA Chemistry and Delivery. Prior to Novartis, Dr. Vargeese served as Vice President of Chemistry at Sirna Therapeutics Inc. since December 23, 2003 and also served as its Director of Chemistry. Dr. Vargeese joined Sirna in 1998 and served as its Director of Chemistry since 2002. At Sirna, Dr. Vargeese developed its proprietary nucleic acid chemistries. Prior to joining Sirna Therapeutics Inc. Dr. Vargeese served as Associate Director of Chemistry at NeXstar Pharmaceuticals, where she was involved in the development of aptamer therapeutics. She is the Co-Inventor of Macugen (pegaptanib). Dr. Vargeese holds a Ph. D. in Organic Chemistry at the Indian Institute of Science, Bangalore, India and completed Post-Doctoral Work at the University of Rhode Island.
Positions
- Company NameWave Life Sciences, Inc.Stock CodeWVEPositionChief Technology OfficerColleagues
